Nomura Holdings’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-40,000
Closed -$2.84M 1799
2023
Q3
$2.84M Buy
+40,000
New +$2.99M 0.01% 702
2022
Q3
Sell
-40,000
Closed -$3.23M 1721
2022
Q2
$3.23M Buy
+40,000
New +$3.13M 0.01% 661
2017
Q1
Sell
-30,000
Closed -$1.97M 1324
2016
Q4
$1.97M Hold
30,000
0.01% 865
2016
Q3
$2.22M Hold
30,000
0.01% 647
2016
Q2
$2.19M Hold
30,000
0.01% 640
2016
Q1
$2.12M Buy
+30,000
New +$2M 0.01% 557
2015
Q1
Sell
-46,400
Closed -$3.21M 1825
2014
Q4
$3.21M Sell
46,400
-15,200
-25% -$1.03M 0.01% 808
2014
Q3
$4.04M Buy
+61,600
New +$4.06M 0.01% 779
2014
Q2
Sell
-58,700
Closed -$3.8M 2771
2014
Q1
$3.8M Buy
+58,700
New +$3.7M ﹤0.01% 869

Other funds holding CL

Nomura Holdings's CL Position: Q2 2026 in Review

Nomura Holdings increased its Colgate-Palmolive (CL) stake by 1,653% in Q2 2026, buying an estimated $3.95M and bringing the position to 47,869 shares worth $4.39M. The position accounts for 0.01% of the portfolio, ranked #839.

Nomura Holdings first reported a position in CL in Q2 2013 and has held it in 49 quarters since. The position peaked at $32.8M in Q3 2020. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Nomura Holdings held 47,869 shares of Colgate-Palmolive worth $4.39M as of Q2 2026.
  • Nomura Holdings bought 45,138 Colgate-Palmolive shares in Q2 2026, an estimated $3.95M.
  • Colgate-Palmolive made up 0.01% of Nomura Holdings's portfolio in Q2 2026, its #839 holding.
  • Nomura Holdings first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 49 quarters since.
  • Nomura Holdings's Colgate-Palmolive position peaked at $32.8M in Q3 2020.
  • 2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.